PEGylated Proteins Market to Reach $5.25 Billion by 2031
Market Analysis The global PEGylated proteins market is valued at USD 4,059 million in 2024 and is expected to reach USD 5,250 million by 2031, registering a CAGR of 3.8% during the forecast period from 2025 to 2031. PEGylation (polyethylene glycol modification) enhances protein stability, solubility, and half-life, making it highly valuable in drug development. Get Free Sample Report: https://www.qyresearch.in/request-sample/pharma-healthcare-global-pegylated-proteins-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031?utm_source=linkedin&utm_medium=Ruchika&utm_campaign=ruchika Key Trends Include Rising application of PEGylated proteins in treating oncology, autoimmune, and infectious diseases . Increasing adoption of site-specific PEGylation technologies for improved drug efficacy and reduced immunogenicity. Growing interest in next-generation biologics and biosimilars integrated with ...